Grantham, Mayo, Van Otterloo & Co (GMO)
INCY icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Incyte INCY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1M Sell
318,584
-46,073
-13% -$4.57M 0.08% 107
2026
Q1 		$34.3M Buy
364,657
+68,312
+23% +$6.82M 0.09% 106
2025
Q4 		$29.3M Buy
296,345
+47,502
+19% +$4.6M 0.07% 117
2025
Q3 		$21.1M Sell
248,843
-56,795
-19% -$4.49M 0.06% 162
2025
Q2 		$20.8M Sell
305,638
-103,044
-25% -$6.53M 0.06% 173
2025
Q1 		$24.7M Sell
408,682
-47,017
-10% -$3.28M 0.08% 166
2024
Q4 		$31.5M Sell
455,699
-125,360
-22% -$8.93M 0.1% 131
2024
Q3 		$38.4M Sell
581,059
-4,653
-0.8% -$297K 0.12% 118
2024
Q2 		$35.5M Buy
585,712
+60,865
+12% +$3.45M 0.12% 116
2024
Q1 		$29.9M Sell
524,847
-15,293
-3% -$918K 0.11% 141
2023
Q4 		$33.9M Buy
540,140
+33,828
+7% +$1.91M 0.15% 121
2023
Q3 		$29.2M Buy
506,312
+85,702
+20% +$5.4M 0.14% 137
2023
Q2 		$26.2M Sell
420,610
-7,890
-2% -$527K 0.12% 153
2023
Q1 		$31M Sell
428,500
-1,500
-0.3% -$117K 0.16% 136
2022
Q4 		$34.5M Buy
430,000
+56,500
+15% +$4.32M 0.18% 116
2022
Q3 		$24.9M Sell
373,500
-10,600
-3% -$783K 0.14% 148
2022
Q2 		$29.2M Buy
384,100
+1,500
+0.4% +$114K 0.16% 130
2022
Q1 		$30.4M Buy
382,600
+62,600
+20% +$4.55M 0.15% 125
2021
Q4 		$23.5M Buy
320,000
+221,300
+224% +$14.9M 0.11% 147
2021
Q3 		$6.79M Buy
+98,700
New +$7.5M 0.03% 294
2017
Q2 		– Sell
-1,500
Closed -$201K – 608
2017
Q1 		$201K Buy
+1,500
New +$191K ﹤0.01% 548

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s INCY Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Incyte (INCY) stake by 13% in Q2 2026, selling an estimated $4.57M and leaving 318,584 shares worth $36.1M. The position accounts for 0.08% of the portfolio, ranked #107.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in INCY in Q1 2017 and has held it in 21 quarters since. The position peaked at $38.4M in Q3 2024. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 318,584 shares of Incyte worth $36.1M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 46,073 Incyte shares in Q2 2026, an estimated $4.57M.
  • Incyte made up 0.08% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #107 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Incyte in Q1 2017 and has held it in 21 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Incyte position peaked at $38.4M in Q3 2024.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.